Physicians with current and valid licenses in the United States, Canada,
or Mexico who read any 3 of the selected continuing medical education (CME)
articles in this issue of JAMA, complete the CME Evaluation Form, and fax
it to the number or mail it to the address at the bottom of the CME Evaluation
Form are eligible for category 1 CME credit. There is no charge.
The American Medical Association (AMA) is accredited by the Accreditation
Council for Continuing Medical Education to sponsor CME for physicians. The
AMA designates this educational activity for up to 1 hour of category 1 CME
credit per JAMA issue toward the AMA Physician's Recognition Award (PRA).
Each physician should claim for credit only those hours that were actually
spent in this educational activity.
Physicians with current and valid licenses in the United States, Mexico,
or Canada are eligible for CME credit even if they live or practice in other
countries. Physicians licensed in other countries are also welcome to participate
in this CME activity. However, the PRA is available only to physicians licensed
in the United States, Canada, or Mexico.
To earn credit, read 3 of the articles listed below that are designated
for CME credit carefully and complete the CME Evaluation Form. The CME Evaluation
Form must be submitted within 1 month of the issue date. A certificate awarding
1 hour of category 1 CME credit will be faxed or mailed to you; it is then
your responsibility to maintain a record of credit received.
One of our goals is to assess continually the educational needs of our
readers so we may enhance the educational effectiveness of JAMA. To achieve
this goal, we need your help. You must complete the CME Evaluation Form to
JAMA is a general medical journal. Its mission and educational purpose
is to promote the science and art of medicine and the betterment of the public
health. A flexible curriculum of article topics is developed annually by THE
JOURNAL's editorial board and is then supplemented throughout the year with
information gained from readers, authors, reviewers, and editors. To accommodate
the diversity of practice types within JAMA's readership, the Reader's Choice
CME activity allows readers, as adult learners, to determine their own educational
needs and to assist the editors in addressing their needs in future issues.
Readers of JAMA should be able to attain the following educational
objectives: (1) select and read at least 3 articles in 1 issue to gain new
medical information on topics of particular interest to them as physicians,
(2) assess the articles' value to them as practicing physicians, and (3) think
carefully about how this new information may influence their own practices.
The educational objective for each CME article is given after the article
Treatment of Postmenopausal OsteoporosisArticle
Educational Objective: To review the latest
evidence regarding the pharmacologic treatment of postmenopausal women with
Physical Activity and Coronary Heart Disease in Women:
Is "No Pain, No Gain" Passé?Article
Educational Objective: To learn that light
to moderate physical activity may reduce coronary heart disease risk in women.
Enhanced Surveillance for Pregnancy-Associated Mortality—Maryland,
Educational Objective: To learn that the leading
cause of death for pregnant women in Maryland is homicide.
Estrogen Replacement Therapy and Ovarian Cancer Mortality
in a Large Prospective Study of US WomenArticle
Educational Objective: To learn that postmenopausal
estrogen use may increase the risk of ovarian cancer mortality.
Mortality, CD4 Cell Count Decline, and Depressive
Symptoms Among HIV Seropositive Women: Longitudinal Analysis From the HIV
Epidemiology Research StudyArticle
Educational Objective: To learn that depressive
symptoms may be associated with progression of HIV disease in women.
Reproductive Period and Risk of Dementia in Postmenopausal
Educational Objective: To learn that the risk
of dementia for women may not be reduced by a longer reproductive period.
Ipriflavone in the Treatment of Postmenopausal Osteoporosis:
A Randomized Controlled TrialArticle
Educational Objective: To learn that ipriflavone
may not prevent bone loss in postmenopausal women.
Hormone Replacement Therapy and Cognition: Systematic
Review and Meta-analysisArticle
Educational Objective: To review the evidence
that hormone replacement therapy may improve cognition or prevent cognitive
decline in postmenopausal women.
After reading 3 of these articles, complete the CME Evaluation Form.
March 21, 2001. JAMA. 2001;285(11):1519-1520. doi:10.1001/jama.285.11.1519